Home » Research » Rumalaya (gel)

Total no. of papers:4 - Clinical Papers:4, Experimental Papers:0
(Research papers based on Indications)

Musculoskeletal disorders

  1. Evaluation of the efficacy and safety of Rumalaya gel in the management of acute and chronic inflammatory musculoskeletal disorders: A open, prospective, non-comparative, phase III clinical trial.
    Singh, R.B., Lifeline Hospital, Varanasi, India, Shilin Giri, Kolhapure, S.A, R&D Center, The Himalaya Drug Company, Bangalore, India. Indian Journal of Clinical Practice (2005): (15), 9, 25.

  2. Comparison of the efficacy and safety of Rumalaya gel with Diclofenac sodium gel in the
    management of various soft tissue injuries and inflammatory musculoskeletal disorders

    Hemant H. Mathur MS (Ortho) Assistant Professor Department of Orthopedics Medical College and S.S.G. Hospital Vadodara. S.A. Kolhapure*, MD Senior Medical Advisor R&D Center The Himalaya Drug Company Bangalore, India [*Corresponding author] Medicine Update 2005.

  3. Evaluation of the efficacy and safety of Rumalaya gel in the management of acute and chronic inflammatory musculoskeletal disorders: An open, prospective, noncomparative, phase III clinical trial
    Ajay Sharma, MS (Ortho)1 and S.A. Kolhapure2*, MD, 1Orthopedic Surgeon, Heritage Hospitals, Varanasi, India 2Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore [*Corresponding author] Medicine Update 2005; 12(10), 39-45.

  4. Evaluation of clinical efficacy and safety of RG-01 (Rumalaya gel) in management of chronic subacute inflammatory joint disorders
    Shishir Rastogi, MS, DNB, Professor Department of Orthopaedics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India Ashish Shukla, M.B.B.S, Senior Research Fellow, Department of Orthopaedics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India and Kolhapure, S.A., M.D., Senior Medical Advisor, R&D Center, The Himalaya Drug Company, Bangalore, India Medicine Update (2004): 12(1), 31-37.